From this paper, we extracted an affinity-balanced
set of 12 peptide pairs of immunogenic and nonimmunogenic binders, and tested both affinity and stability of their interaction with HLA-A*02:01. By and large, we confirmed the reported affinity data. Importantly, we found a highly significant correlation between high stability and immunogenicity (a half-life of 14 h for the immunogenic binders versus 3 h for the nonimmunogenic binders, p = 0.0007). Thus, this affinity-balanced reanalysis of the unbiased data reported by Sette and colleagues confirms that the stability of pMHC-I complexes contributes to the definition of immunogenicity, and that stability is a better indicator of immunogenicity than affinity is. This experimental analysis was subsequently corroborated by a bioinformatics-driven analysis. Our data suggest that the description and relative contribution of antigen Enzalutamide concentration processing and presentation events needs to be redefined. Nonimmunogenic binders are usually considered to be the result of “holes in the T-cell repertoire.” However, a failure to achieve stable interaction with MHC may be considered an alternative mechanism of lacking immunogenicity, as a “hole in the stably bound MHC repertoire”
mechanism, which would go unnoticed when solely addressing the affinity of peptide-MHC-I interactions. This may account for as much as 30% of these instances of lacking immunogenicity and it follows that a method
to predict the stability of pMHC-I complexes might support computational CTL epitope discovery. MG-132 ic50 Finally, both our experimental and bioinformatics-driven BGB324 analysis suggested that the lack of stability of HLA-A*02:01 binding occurred when the P2 anchor residue was not optimal. Although both threonine and glutamine can be found in P2 of high-affinity binding peptides, they lead to a seven to tenfold reduction in stability compared to the optimal leucine. Thus, it would appear that one anchor might be sufficient for binding, whereas two anchors might be needed to obtain stable MHC-I interaction. This is reminiscent of a previous suggestion that the different pockets of the MHC-II can be seen as interacting with peptide independently, and that destabilizing any of the pockets individually may lead to peptide dissociation [[39]]. Thus, pMHC-I stability studies should help elucidating how peptide bind and remain bound to MHC-I, and how MHC-I matures and eventually becomes a bona fide CTL target. Peptides were synthesized by Schafer-N (Copenhagen, Denmark) by Fmoc chemistry and HPLC purified to at least more than 80% (usually >95%), analyzed by HPLC and MS, and quantitated by weight. Synthetic genes encoding MHC-I heavy chains were generated as previously described [[40, 41]]. Briefly, genes encoding MHC-I heavy chains truncated at position 275 (i.e.